Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Oxalis Labs | Solan, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyJun 2, 2023 · 2 inspections |
Product details
- Generic drug
- Repaglinide: every company that makes it
- Form
- tablet, oral
- Strength
- 0.5 mg
- Approval
- ANDA ANDA207209
- On the market since
- Apr 8, 2025
- Package NDCs
72603-810-01- Official label
- DailyMed (National Library of Medicine), updated Sep 15, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?